BridgeBio Pharma (BBIO) Times Interest Earned (2019 - 2025)
Historic Times Interest Earned for BridgeBio Pharma (BBIO) over the last 7 years, with Q3 2025 value amounting to -$12.37.
- BridgeBio Pharma's Times Interest Earned fell 4875.63% to -$12.37 in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.03, marking a year-over-year increase of 1714.31%. This contributed to the annual value of -$5.97 for FY2024, which is 2007.04% up from last year.
- Latest data reveals that BridgeBio Pharma reported Times Interest Earned of -$12.37 as of Q3 2025, which was down 4875.63% from -$3.57 recorded in Q2 2025.
- BridgeBio Pharma's Times Interest Earned's 5-year high stood at $0.01 during Q1 2024, with a 5-year trough of -$17.2 in Q1 2021.
- For the 5-year period, BridgeBio Pharma's Times Interest Earned averaged around -$7.77, with its median value being -$7.65 (2024).
- As far as peak fluctuations go, BridgeBio Pharma's Times Interest Earned skyrocketed by 10023.31% in 2024, and later tumbled by 1704792.92% in 2025.
- BridgeBio Pharma's Times Interest Earned (Quarter) stood at -$10.94 in 2021, then soared by 40.92% to -$6.46 in 2022, then plummeted by 35.4% to -$8.75 in 2023, then grew by 13.41% to -$7.58 in 2024, then plummeted by 63.19% to -$12.37 in 2025.
- Its Times Interest Earned was -$12.37 in Q3 2025, compared to -$3.57 in Q2 2025 and -$2.48 in Q1 2025.